Framework agreement for Aflibercept supply
Original notice title
Belgium – Various medicinal products – Raamovereenkomst voor de levering van Aflibercept
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
60 / 100
Risk factors
Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...
Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- AZ Sint-Lucas vzw
- Country
- Belgium
- CPV
- 33690000 - Various medicinal products
- Deadline
- Jul 31, 2026
- Estimated value
- EUR 5.8M
Overview
Moderate opportunityKey Facts
- EUR 5.8M estimated value
- Framework procurement
- Supplies contract
- 3 lots
- Duration until Sep 2030
- Supply of Aflibercept (40mg/1ml) medicinal products in two forms: prefilled syringes and vials.
- Three lots corresponding to different product forms and therapeutic indications.
Show full summary
This is an open tender from AZ Sint-Lucas vzw in Belgium for the supply of Aflibercept (40mg/1ml) medicinal product. It is divided into three lots: Lot 1 covers prefilled syringes for multiple ophthalmic indications, Lot 2 covers prefilled syringes for retinopathy of prematurity (ROP), and Lot 3 covers vials. Each lot is a framework agreement with a 2-year initial term and two silent 1-year extensions. The total maximum framework value across all lots is EUR 5,803,284 (from XML notice). Award is based primarily on price (82-87%) with quality subcriteria. Electronic submission is required through publicprocurement.be. The tender language is Dutch only. Key risks include short submission window, strict eligibility criteria (financial standing, FAGG license, ESPD), and potential inconsistencies in EU funding status. Procurement documents were not analyzed.
Risks
Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...
Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Submission language: Dutch only.
- Electronic submission via publicprocurement.be is mandatory.
- Bidders can submit for up to 3 lots.
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Lot 3
Buyer
Location
Brugge, BEL
Website
Buyer profile
Identifier
408.116.216
Activity
Health
Lots (3)
LOT-0001
Aflibercept Pre-filled Syringe – Multiple Indications
Supply of Aflibercept (40mg/1ml) prefilled syringe registered for: neovascular age-related macular degeneration, visual impairment due to macular edema secondary to retinal vein occlusion, diabetic macular edema, and myopic choroidal neovascularization.
EUR 5.7M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Prijs
flexibiliteit van de bewaarcondities
Gebruiksgemak en veiligheid
Productieplaats
Value note
Framework maximum value
Show original TED data
Original lot title
Aflibercept (40mg/1ml) - Voorgevulde spuit
Original TED description
geregistreerd voor volgende indicaties: 1. neovasculaire (natte) leeftijdsgebonden maculadegeneratie (LMD) 2. visusverslechtering als gevolg van macula-oedeem secundair aan retinale veneuze occlusie 3. visusverslechtering als gevolg van diabetisch macula-oedeem (DME) 4. visusverslechtering als gevolg van myope choroïdale neovascularisatie (myope CNV)
LOT-0002
Aflibercept Pre-filled Syringe – ROP
Supply of Aflibercept (40mg/1ml) prefilled syringe registered for the treatment of retinopathy of prematurity (ROP).
EUR 8.5k
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Prijs
flexibiliteit van de bewaarcondities
Gebruiksgemak en veiligheid
Productieplaats
Value note
Framework maximum value
Show original TED data
Original lot title
Aflibercept (40mg/1ml) - Voorgevulde spuit
Original TED description
geregistreerd voor de volgende indicatie: 1. de behandeling van een oogaandoening met de naam prematuren-retinopathie (ROP)
LOT-0003
Aflibercept Vial
Supply of Aflibercept (40mg/1ml) in vial form.
EUR 98.4k
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Prijs
flexibiliteit van de bewaarcondities
Productieplaats
Value note
Framework maximum value
Show original TED data
Original lot title
Aflibercept (40mg/1ml) - Flacon
Original TED description
Aflibercept (40mg/1ml) - Flacon
Procurement Details
- Publication date
- 01 Jul 2026
- Languages
- Dutch
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 455937-2026
Documents (2)
Similar tenders
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
60 / 100
Risk factors
Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...
Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications